arrow
T

Tero Aittokallio

University of Turku
H-index:73
Citation Count:1.9万
Views:0

Biography

No content for now.

Education

No content for now.

Work Experience

No content for now.

Honors & Awards

No content for now.

Estimating the completeness of large-scale single-cell sequencing projects

大规模单细胞测序项目的完整性评估

2026-10-080
OAAI
An integrated spatially defined roadmap of normal and cancer-associated colon fibroblasts

正常和癌症相关结肠成纤维细胞的整合空间定义路线图

2026-09-230
OAAI
A functional prognostic model predicts progression-free survival in patients with relapsed chronic lymphocytic leukemia treated with ibrutinib + venetoclax

一种功能性预后模型预测接受伊布替尼联合维奈克拉治疗复发性慢性淋巴细胞白血病患者无进展生存期

2026-09-180
OAAI
Multi-modal learning with incomplete data

基于不完整数据的多模态学习

2026-08-310
OA
A host-centric morphological profiling approach to identify repurposed antiviral drugs

以宿主为中心的形态学分析新方法用于识别新用途的抗病毒药物

2026-07-010
OAAI
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib

具有激活STAT5B突变的肝脾 γ δ T细胞淋巴瘤的临床前模型对JAK抑制剂upadacitinib敏感

2026-04-160
OAAI
Prognostic biomarker discovery in pancreatic cancer through hybrid ensemble feature selection and multi-omics data

通过混合集成特征选择和多组学数据发现胰腺癌预后生物标志物

2026-04-090
OAAI
Discovery of predictive biomarkers for cancer therapy through computational approaches

通过计算方法发现癌症治疗的预测性生物标志物

2026-01-060
PRE
Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool

采用全面的统计框架和网页工具改进体内药物组合实验的分析

2025-11-190
OAAI
Path-based quantification of activation and repression in Boolean models using BooLEVARD

基于BooLEVARD的布尔模型中激活和抑制的路径量化

2025-11-190
OAAI
Breast cancer remodels lymphatics in sentinel lymph nodes

乳腺癌重塑哨兵淋巴结的淋巴管

2025-11-170
OAAI
Spatial artifact detection improves the reproducibility of drug screening experiments

空间伪影检测提高了药物筛选实验的可重复性

2025-08-300
OAAI
Discovery of molecularly-informed therapeutic strategies for mature T-cell leukemias and lymphomas

基于分子信息的成熟T细胞白血病和淋巴瘤的治疗策略发现

2025-08-060
OAAI
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient

蛋白酶体抑制在B细胞恶性模型和索引患者中克服靶向治疗耐药性

2025-07-230
OA
From library to landscape: integrative annotation workflows for compound libraries in drug repurposing

从图书馆到景观:药物重定位中化合物库的整合注释工作流程

2025-01-010
OAAI
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma

双重特异性STAT3/5降解剂有效阻断急性髓系白血病和自然杀伤/T细胞淋巴瘤

2024-11-280
OAAI
Validation guidelines for drug-target prediction methods

药物靶点预测方法验证指南

2024-11-210
OA
Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones

单细胞转录组鉴定针对癌症克隆的选择性共抑制的患者定制疗法

2024-10-030
OAAI
Editorial overvie-Artificial intelligence methodologies in structural biology: Bridging the gap to medical applications

社论overvie-结构生物学中的人工智能方法: 弥合与医学应用的差距

2024-08-011
PRE
RepurposeDrugs: an interactive web-portal and predictive platform for repurposing mono- and combination therapies

重新利用药物: 一个交互式门户网站和预测平台,用于重新利用单一疗法和联合疗法

2024-07-092
OAAI